Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-155873

ACCELERON PHARMA INC · XLRN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jean George
Director
Period of report
Dec 7, 2016
Accepted (ET)
Dec 19, 2016 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280600

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Dec 7, 2016M127,122$5.88A127,122ISee footnote
Common StockF3,F2Dec 7, 2016F22,000$33.98D105,122ISee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrants to Purchase Common StockF1,F2,F4$5.88Dec 7, 2016M127,122D—Jun 10, 2020Common Stock127,1220I

Explanation of responses